QQQ $ 604.96 nm (nm)
DIA $ 462.22 nm (nm)
SPY $ 665.07 nm (nm)
TLT $ 91.08 nm (nm)
GLD $ 391.24 nm (nm)
$ 0.6597
-- x --
-- x --
-- - --
$ 0.52 - $ 2.45
2,416
na
1.18M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-17-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-20-2022 03-31-2022 10-Q
15 04-15-2022 12-31-2021 10-K
16 11-22-2021 09-30-2021 10-Q
17 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 carmells-kendra-bracken-ferguson-departs-as-ceo-rajiv-shukla-appointed-as-new-ceo

- SEC Filing

 why-biotechnology-company-carmell-shares-are-rocketing-on-thursday

Carmell Corp. (NASDAQ: CTCX) to acquire Elevai Skincare for $1.1 million with additional payments and assets, solidifying their...

 carmell-shares-resumed-trade
Carmell Shares Resumed Trade
01/02/2025 14:41:52

 update-consideration-includes-11m-in-carmell-common-stock-57k-in-cash-upon-sale-of-specified-inventory-and-contingent-earnout

The purchase consideration for the Acquisition is as follows:Approximately $1.1 million in Carmell common stock at the closing ...

 carmell-announces-agreement-to-acquire-elevai-skincare

The purchase consideration for the Acquisition is as follows:Approximately $1.1 million in Carmell common stock at the closing ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION